APA (7th ed.) Citation

SK, P., S, R., J, L., KSR, P., LD, C., H, S., . . . R, K. (2026). FLT3-SYK inhibitor and Ixazomib combination impact HOXA and oxidative stress control by β-catenin, SQSTM1 and NRF2 in AML. NPJ precision oncology, 10(1), . https://doi.org/10.1038/s41698-026-01332-1

Chicago Style (17th ed.) Citation

SK, Pasupuleti, et al. "FLT3-SYK Inhibitor and Ixazomib Combination Impact HOXA and Oxidative Stress Control by β-catenin, SQSTM1 and NRF2 in AML." NPJ Precision Oncology 10, no. 1 (2026). https://doi.org/10.1038/s41698-026-01332-1.

MLA (9th ed.) Citation

SK, Pasupuleti, et al. "FLT3-SYK Inhibitor and Ixazomib Combination Impact HOXA and Oxidative Stress Control by β-catenin, SQSTM1 and NRF2 in AML." NPJ Precision Oncology, vol. 10, no. 1, 2026, https://doi.org/10.1038/s41698-026-01332-1.